[综述] 重新定义疾病消除:柳叶刀慢性阻塞性肺疾病委员会的最新进展
完整摘要 · 中文译文
慢性阻塞性肺疾病(COPD)仍是全球发病和死亡的主要原因之一,人口增长与老龄化、持续的有害暴露以及严重的健康不平等推动着全球疾病负担不断加重。《柳叶刀》COPD委员会提出了通过预防、早期发现和干预实现消除该疾病的宏伟愿景。本综述重温该愿景,评估自2022年以来的进展,并作为对委员会的更新,呼吁对终身肺部健康作出更广泛的承诺。本综述分七个部分,提出一个统一框架,整合肺发育与衰老生物学、精准医学、以患者为中心的结局以及监管改革。COPD并非单一、均一的疾病;而是一种生物学上复杂的病症,在整个生命历程中受遗传、发育、环境、感染和行为因素塑造。因此,有效的预防和照护应超越对晚期生理损害的发现和治疗,转向更早期的疾病识别、生物学分层以及旨在维护肺部健康、减轻症状、预防发病和过早死亡的干预措施。本综述勾勒了一条从被动、晚期管理转向主动、公平、基于精准的预防和照护的路径。核心前提明确无疑:COPD的全球负担可以大幅降低。成功不仅应以肺功能和生存的改善来衡量,还应以日常功能、生活质量和幸福感的改善来衡量。在这一扩展的 从这一视角来看,慢性阻塞性肺疾病(COPD)不再仅仅被视为一种需要管理的慢性疾病,而是被视为在更广泛的终身肺部健康承诺中一种可预防、可改变的疾病状态。
完整摘要 · 英文原文
Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide, with increasing global burden driven by population growth and ageing, persistent harmful exposures, and substantial health inequities. The Lancet Commission on COPD articulated an ambitious vision for disease elimination with prevention, early detection, and intervention. This Review revisits that vision, assesses progress since 2022, and calls for a broader commitment to lifelong lung health as an update of the Commission. Across seven sections, this Review advances a unified framework integrating the biology of lung development and ageing, precision medicine, patient-centred outcomes, and regulatory reform. COPD is not a single, uniform disease; rather, a biologically complex condition shaped by genetic, developmental, environmental, infectious, and behavioural factors across the entire life course. Effective prevention and care should therefore move beyond the detection and treatment of late physiological impairment toward earlier disease recognition, biological stratification, and interventions to preserve lung health, reduce symptoms, and prevent morbidity and premature mortality. The Review charts a path from reactive, late-stage management toward proactive, equitable, precision-based prevention and care. The central premise is unequivocal: the global burden of COPD can be substantially reduced. Success should be measured not only by gains in lung function and survival but also by improvements in daily functioning, quality of life, and wellbeing. In this expanded vision, COPD is no longer viewed solely as a chronic disease to be managed but as a preventable and modifiable condition within a broader commitment to lifelong lung health.